What About AbbVie?
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of analyst estimates.… Read More »What About AbbVie?
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of analyst estimates.… Read More »What About AbbVie?
The best tech stocks to buy and short this month may be ones that have little to do with the attention-grabbing headlines the sector is… Read More »The Long & Short Of Trading Tech This May
One positive effect of COVID-19? It has created a situation where high-quality preferred stocks – and their generous yields – are available at some of… Read More »The Pandemic Has Made Preferreds Even More Attractive